A Predictive Model of Mortality in Patients With Bloodstream Infections due to Carbapenemase-Producing Enterobacteriaceae

Mayo Clinic Proceedings

Volumn 91, Issue 10, 2016, Pages 1362-1371

  Gutiérrez Gutiérrez, Belén ^a   Salamanca, Elena ^a   de Cueto, Marina ^a   Pascual, Alvaro ^a,ac   Rodríguez Baño, Jesús ^a,ac   Hsueh, Po Ren ^b   Viale, Pierluigi ^c   Paño Pardo, José Ramón ^d,e   Venditti, Mario ^f   Tumbarello, Mario ^g   Daikos, George ^h   Pintado, Vicente ⁱ   Doi, Yohei ^j   Tuon, Felipe Francisco ^k   Karaiskos, Ilias ^l   Machuca, Isabel ^m   Schwaber, Mitchell J ⁿ   Azap, O K ^ad   Souli, Maria ^p   Roilides, Emmanuel ^q   Pournaras, Spyros ^r   Akova, Murat ^s   Pérez, Federico ^t   Bonomo, Robert A ^t,z   Bermejo, Joaquín ^u   Oliver, Antonio ^v   Almela, Manel ^w   Lowman, Warren ^x   Almirante, Benito ^y   Carmeli, Yehuda ^n,aa   Paterson, David L ^ab   Falcone, M ^ad   Russo, A ^ad   Giamarellou, H ^ad   Trecarichi, E M ^ad   Losito, A R ^ad   Garcia Vazquez E ^ad   Hernandez A ^ad   Gomez J ^ad   Iosifidis, E ^ad   Prim, N ^ad   Navarro, F ^ad   Mirelis, B ^ad   Origuen J ^ad   San Juan, R ^ad   Fernandez Ruiz M ^ad   Larrosa, N ^ad   Puig Asensio, M ^ad   Cisneros, J M ^ad   Molina, J ^ad   Gonzalez V ^ad   Rucci, V ^ad   Ruiz de Gopegui, E ^ad   Marinescu, C I ^ad   Martinez Martinez L ^ad   Farinas M C ^ad   Cano, M E ^ad   Gozalo, M ^ad   Mora Rillo, M ^ad   Navarro San Francisco, C ^ad   Pena C ^ad   Gomez Zorrilla S ^ad   Tubau, F ^ad   Tsakris, A ^ad   Zarkotou, O ^ad   Pitout, J ^ad   Virmani, D ^ad   Torre Cisneros, J ^ad   Natera, C ^ad   Helvaci, O ^ad   Sahin, A O ^ad   Canton R ^ad   Ruiz, P ^ad   Bartoletti, M ^ad   Giannella, M ^ad   Taconelli, E ^ad   Riemenschneider, F ^ad   Calbo, E ^ad   Badia, C ^ad   Xercavins, M ^ad   Gasch, E ^ad   Fontanals, D ^ad   Jove E ^ad   more..

^a Instituto de Biomedicina de Sevilla   (Spain)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c UNIVERSITY OF BOLOGNA   (Italy)

^d HOSPITAL UNIVERSITARIO LA PAZ IDIPAZ   (Spain)

^e HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA   (Spain)

^f SAPIENZA UNIVERSITY OF ROME   (Italy)

^g CATHOLIC UNIVERSITY   (Italy)

^h UNIVERSITY OF ATHENS   (Greece)

ⁱ HOSPITAL RAMÓN Y CAJAL   (Spain)

^j UNIVERSITY OF PITTSBURGH   (United States)

^k FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^l IASO GENERAL HOSPITAL   (Greece)

^m HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

ⁿ TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^o BASKENT UNIVERSITY   (Turkey)

^p NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^q Aristotle University of Thessaloniki   (Greece)

^r UNIVERSITY OF THESSALY   (Greece)

^s HACETTEPE UNIVERSITY   (Turkey)

^t LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

^u HOSPITAL ESPAÑOL   (Argentina)

^v HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

^w HOSPITAL CLÍNIC   (Spain)

^x University of the Witwatersrand   (South Africa)

^y HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^z CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^aa MINISTRY OF HEALTH   (Israel)

^ab UNIVERSITY OF QUEENSLAND   (Australia)

^ac UNIVERSITY OF SEVILLE   (Spain)

^ad Universidad de Sevilla ^*

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BILIARY TRACT INFECTION; BLOODSTREAM INFECTION; CARBAPENEMASE PRODUCING ENTEROBACTERIACEAE; CAUSE OF DEATH; CHARLSON COMORBIDITY INDEX; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTION; PREDICTIVE VALUE; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SEPSIS; SHOCK; URINARY TRACT INFECTION; BACTEREMIA; CLINICAL TRIAL; COMORBIDITY; DECISION SUPPORT SYSTEM; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; METABOLISM; MICROBIOLOGY; MIDDLE AGED; MULTICENTER STUDY; STATISTICAL MODEL; VALIDATION STUDY;

ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; BETA LACTAMASE; CARBAPENEMASE;

AGED; ANTI-BACTERIAL AGENTS; BACTEREMIA; BACTERIAL PROTEINS; BETA-LACTAMASES; COMORBIDITY; DECISION SUPPORT TECHNIQUES; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 84994355438     PISSN: 00256196     EISSN: 19425546     Source Type: Journal    
DOI: 10.1016/j.mayocp.2016.06.024     Document Type: Article

References (25)

1. 1 World Health Organization, Antimicrobial Resistance: Global Report on Surveillance, 2014. 2014, World Health Organization, Geneva, 1–256.
2. 2 Tzouvelekis, L.S., Markogiannakis, A., Psichogiou, M., Tassios, P.T., Daikos, G.L., Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions. Clin Microbiol Rev 25:4 (2012), 682–707.
3. 3 Qureshi, Z.A., Paterson, D.L., Potoski, B.A., et al. Treatment outcome of bacteremia due to KPC-producing Klebsiella pneumoniae: superiority of combination antimicrobial regimens. Antimicrob Agents Chemother 56:4 (2012), 2108–2113.
4. 4 Tumbarello, M., Viale, P., Viscoli, C., et al. Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy. Clin Infect Dis 55:7 (2012), 943–950.
5. 5 Zarkotou, O., Pournaras, S., Tselioti, P., et al. Predictors of mortality in patients with bloodstream infections caused by KPC-producing Klebsiella pneumoniae and impact of appropriate antimicrobial treatment. Clin Microbiol Infect 17:12 (2011), 1798–1803.
6. 6 Daikos, G.L., Tsaousi, S., Tzouvelekis, L.S., et al. Carbapenemase-producing Klebsiella pneumoniae bloodstream infections: lowering mortality by antibiotic combination schemes and the role of carbapenems. Antimicrob Agents Chemother 58:4 (2014), 2322–2328.
7. 7 Navarro-San Francisco, C., Mora-Rillo, M., Romero-Gómez, M.P., et al. Bacteraemia due to OXA-48-carbapenemase-producing Enterobacteriaceae: a major clinical challenge. Clin Microbiol Infect 19:2 (2013), E72–E79.
8. 8 Rodríguez-Baño, J., Cisneros, J.M., Cobos-Trigueros, N., et al., Study Group of Nosocomial Infections (GEIH) of the Spanish Society of Infectious Diseases, Infectious Diseases (SEIMC). Diagnosis and antimicrobial treatment of invasive infections due to multidrug-resistant Enterobacteriaceae: guidelines of the Spanish Society of Infectious Diseases and Clinical Microbiology. Enferm Infecc Microbiol Clin 33:5 (2015), 337e1–337e21.
9. 9 Charlson, M.E., Pompei, P., Ales, K.L., MacKenzie, C.R., A new method of classifying prognostic co-morbidity in longitudinal studies: development and validation. J Chronic Dis 40:5 (1987), 373–383.
10. 10 Hilf, M., Vh, Yu, Sharp, J., Zuravleff, J.J., Korvick, J.A., Muder, R.R., Antibiotic therapy for Pseudomonas aeruginosa bacteremia: outcome correlations in a prospective study of 200 patients. Am J Med 87:5 (1989), 540–546.
11. 11 Levy, M.M., Fink, M.P., Marshall, J.C., et al., SCCM/ESICM/ACCP/ATS/SIS. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definition Conference. Crit Care Med 31:4 (2003), 1250–1256.
12. 12 Daikos, G.L., Markogiannakis, A., Carbapenemase-producing Klebsiella pneumoniae: (when) might we still consider treating with carbapenems?. Clin Microbiol Infect 17:8 (2011), 1135–1141.
13. 13 Clinical and Laboratory Standards Institute, Performance Standards for Antimicrobial Susceptibility Testing. CLSI document M100–S22, 2012, Clinical and Laboratory Standards Institute, Wayne, PA.
14. 14 Neuner, E.A., Yeh, J.Y., Hall, G.S., et al. Treatment and outcomes in carbapenem-resistant Klebsiella pneumoniae bloodstream infections. Diagn Microbiol Infect Dis 69:4 (2011), 357–362.
15. 15 Ben-David, D., Kordevani, R., Keller, N., et al. Outcome of carbapenem resistant Klebsiella pneumoniae bloodstream infections. Clin Microbiol Infect 18:1 (2012), 54–60.
16. 16 Capone, A., Giannella, M., Fortini, D., et al., SEERBIO-GRAB network. High rate of colistin resistance among patients with carbapenem-resistant Klebsiella pneumoniae infection accounts for an excess of mortality. Clin Microbiol Infect 19:1 (2013), E23–E30.
17. 17 Schwaber, M.J., Klarfeld-Lidji, S., Navon-Venezia, S., Schwartz, D., Leavitt, A., Carmeli, Y., Predictors of carbapenem-resistant Klebsiella pneumoniae acquisition among hospitalized adults and effect of acquisition on mortality. Antimicrob Agents Chemother 52:3 (2008), 1028–1033.
18. 18 Daikos, G.L., Petrikkos, P., Psichogiou, M., et al. Prospective observational study of the impact of VIM-1 metallo-β-lactamase on the outcome of patients with Klebsiella pneumoniae bloodstream infections. Antimicrob Agents Chemother 53:5 (2009), 1868–1873.
19. 19 Mouloudi, E., Protonotariou, E., Zagorianou, A., et al. Bloodstream infections caused by metallo-β-lactamase/Klebsiella pneumoniae carbapenemase-producing K. pneumoniae among intensive care unit patients in Greece: risk factors for infection and impact of type of resistance on outcomes. Infect Control Hosp Epidemiol 31:12 (2010), 1250–1256.
20. 20 Pintado, V., Ruiz-Garbajosa, P., Cobo, J., et al. Aparición secuencia de enterobacterias productoras de carbapenemasas VIM-1, KPC-3 y OXA-48 en un hospital terciario. XVIII Congreso de la Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica (SEIMC), 2014. Abstrat 024. En ferm Infecc Microbiol Clin, 32(Especial Cong 1), 2014, 29 Accesible at: http://www.elsevier.es/es-revista-enfermedades-infecciosas-microbiologia-clinica-28-articulo-abstracts-comunicaciones-X0213005X14908777.
21. 21 Patel, G., Huprikar, S., Factor, S.H., Jenkins, S.G., Calfee, D.P., Outcomes of carbapenem- resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies. Infect Control Hosp Epidemiol 29:12 (2008), 1099–1106.
22. 22 Falagas, M.E., Lourida, P., Poulikakos, P., Rafailidis, P.I., Tansarli, G.S., Antibiotic treatment of infections due to carbapenem-resistant Enterobacteriaceae: systematic evaluation of the available evidence. Antimicrob Agents Chemother 58:2 (2014), 654–663.
23. 23 Retamar, P., Portillo, M.M., López-Prieto, M.D., et al., SAEI/SAMPAC Bacteremia Group. Impact of inadequate empirical therapy on the mortality of patients with bloodstream infections: a propensity score-based analysis. Antimicrob Agents Chemother 56:1 (2012), 472–478.
24. 24 Paterson, D.L., Ko, W.C., Von Gottberg, A., et al. International prospective study of Klebsiella pneumoniae bacteremia: implications of extended-spectrum beta-lactamase production in nosocomial infections. Ann Intern Med 140:1 (2004), 26–32.
25. 25 Rodríguez-Baño, J., Picón, E., Gijón, P., et al., Spanish Network for Research in Infectious Diseases (REIPI). Community-onset bacteremia due to extended-spectrum beta-lactamase-producing Escherichia coli: risk factors and prognosis. Clin Infect Dis 50:1 (2010), 40–48.